Related Science News

NineSigma’s client is a leading global pharmaceutical company at the forefront of state-of-the-art biopharmaceutical research and innovation. As part of their innovation pursuits, they are launching a novel new treatment for Psoriasis, a chronic autoimmune disease that impacts over 125 million individuals globally. Psoriasis is characterized by red, scaly patches of […]

As we get older, it's normal for our thinking and memory skills to change, and there is a common misconception that a decline in mental faculties is somehow an acceptable facet of the aging process. While some decline is expected, how much is normal? Understanding what's considered a typical part […]